Current Opinion in Organ Transplantation

Article	Citations
Survival in adult lung transplantation: where are we in 2020?	130
Uterus transplantation worldwide: clinical activities and outcomes	45
Artificial intelligence and organ transplantation: challenges and expectations	26
Nonmedical barriers to early steps in kidney transplantation among underrepresented groups in the United States	24
Current status of porcine islet xenotransplantation	23
Continuous distribution as an organ allocation framework	23
The artificial pancreas	22
Gender and racial disparities in the transplant surgery workforce	20
Ethical considerations in xenotransplantation: a review	16
Development of a UK liver transplantation selection and allocation scheme	16
Elucidating measures of systemic racism to mitigate racial disparities in kidney transplantation	15
Update on islet cell transplantation	15
Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis	15
Update on Nocardia infections in solid-organ transplantation	14
United States liver allocation	13
The time is now: antimicrobial stewardship in solid organ transplantation	13
The current status and outlook of trachea transplantation	13
Machine-learning algorithms for predicting results in liver transplantation: the problem of donor–recipient matching	13
Viability testing during liver preservation	12
Artificial intelligence in transplantation (machine-learning classifiers and transplant oncology)	12
Biomarkers of rejection in liver transplantation	12
Current status of pediatric intestinal transplantation in the United States	12
Normothermic machine perfusion of donor-lungs ex-vivo: promoting clinical adoption	12
Kidney transplantation following uncontrolled donation after circulatory death	12
Mitochondria and ischemia reperfusion injury	12

Update on immunosuppressive strategies in intestinal transplantation	11
Long-term outcomes of intestinal transplantation	11
New insights into the indications for intestinal transplantation	11
Tolerance studies in liver transplantation: are we fooling ourselves?	11
Donor-specific antibodies in lung transplantation	11
Gender disparities in transplantation	11
New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment	11
Current status of intestinal transplantation in East Asia	11
Grant monitoring after intestinal transplantation	10
An opposing view to United States liver allocation problems with broader sharing	10
Antibody-mediated rejection: prevention, monitoring and treatment dilemmas	10
Current state of adult intestinal transplantation in Europe	10
Current status of normothermic ex-vivo perfusion of cardiac allografts	10
Geographic disparities in transplantation	10
Disparities in heart and lung transplantation	10
Dissecting the human kidney allograft transcriptome: single-cell RNA sequencing	9
The past the present and the future of face transplantation	9
Novel approaches in uterus transplantation	9
Cardiac evaluation of the kidney or liver transplant candidate	9
The rise and fall of the model for end-stage liver disease score and the need for an optimized machine learning approach for liver allocation	9
The evolving role of ECMO in liver transplantation	9
Pancreas preservation: clinical practice and future developments	9
Current status of pediatric mechanical circulatory support	9
Comparing bowel lengthening procedures: which, when, and why?	8
MicroRNAs: small molecules, big effects	8
Cardiac donation after circulatory death	8
Developments in immunosuppression	8
Access to liver transplantation for minority populations in the United States	8
Cell-free DNA in lung transplantation: research tool or clinical workhorse?	8
The use of organs from hepatitis C virus-viremic donors into uninfected recipients	8
Donor-specific antibody and sensitized patients in intestinal transplantation	8
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation	8
A detailed analysis of the current status of intestinal transplantation in Latin America	8
An update on frailty in lung transplantation	8
Current status of adult liver transplantation: utilization of living donor versus deceased donor graft	8
Role of the purinergic signaling network in lung ischemia-reperfusion injury	8
Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process	8
Intestinal transplantation	8
Increased-risk donors and solid organ transplantation: current practices and opportunities for improvement	7
The role of non-HLA antibodies in solid organ transplantation: a complex deliberation	7
Recent advances in precision medicine for individualized immunosuppression	7
Immune benefit of combined heart and liver transplantation	7
Liver perfusion strategies: what is best and do ischemia times still matter?	7
Total artificial heart as a bridge to transplantation	7
Ethics of allocation of donor organs	7
Current status of left lobe adult to adult living donor liver transplantation	7
Redefining marginality: donor lung criteria	7
The emerging psychosocial profile of the adult congenital heart disease patient	7
Lung transplant programs in developing countries: challenges, solutions, and outcomes	7
Adult intestinal transplantation in the United States	7

Alloimmunity in pancreas transplantation	7
Precision transplant pathology	6
Procedural mechanical support for lung transplantation	6
Heart transplantation candidacy	6
Expanding access to pancreas transplantation for type 2 diabetes mellitus	6
Pediatric kidney transplantation in the United States	6
Considerations and experience driving expansion of combined heart–liver transplantation	6
The impact of the gut microbiome on liver transplantation	6
Machine learning methods in organ transplantation	6
Psychosocial considerations in the combined bariatric surgery and organ transplantation population: a review of the overlapping pathologies and outcomes	6
New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients	6
Antibody-medicated rejection after heart transplantation: diagnosis and clinical implications	6
Mycobacterium tuberculosis in solid organ transplant donors and recipients	6
Quality of life after intestinal transplantation	6
Marginal parental donors for pediatric living donor liver transplantation	5
Technical advancements in epigenomics and applications in transplantation	5
Uterus transplantation: ethical considerations	5
Organ allocation in the age of the algorithm: avoiding futile transplantation – utility in allocation	5
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation	5
The solid organ transplant recipient with SARS-CoV-2 infection	5
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics	5
Skin xenotransplantation: technological advances and future directions	5
Disparities in living donation	5
Ethical and societal challenges in penis transplantation	5
Delayed graft function: current status and future directions	5
Age disparities in transplantation	5
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients	5
Development and outcomes of the French liver allocation system	5
Normothermic regional perfusion for donation after circulatory death donors	5
Intestinal transplantation: an overview of the recent experimental studies	5
New insights into the microbiome in kidney transplantation	5
Obesity and kidney transplantation	5
Pancreas transplantation	5
Uterus transplantation – donor and recipient work-up	5
The current state of artificial intelligence in cardiac transplantation	5
Normothermic machine perfusion of kidneys: current strategies and future perspectives	5
A detailed analysis of the current status of intestinal transplantation in the middle east	5
Current status: meeting the regulatory goals of your liver transplant program	4
Lung transplantation: candidate selection and timing of transplant	4
Limitations and limits and of vascularized composite allotransplantations: can we reach the holy grail?	4
Novel biomarkers of chronic lung allograft dysfunction: is there anything reliable?	4
Primary graft dysfunction	4
Effects of the complement system on antibody formation and function: implications for transplantation	4
Basic principles of liver allocation and development over the years	4
Variations in DNA methylation and allograft rejection	4
Cardiomyopathies in children: classification, diagnosis and treatment	4
The use of marginal kidneys in dual kidney transplantation to expand kidney graft utilization	4
Recurrent glomerulonephritis after kidney transplantation: a practical approach	4
Robotic live donor hysterectomy	4
Delayed kidney transplantation in combined liver-kidney transplantation	4
Depression in transplantation	4
Current state of kidney utilization in multiorgan transplants	4
Research priorities in Fontan-associated liver disease	4
The current status of virus-positive liver transplantation	4
Expedited placement to maximize utilization of marginal organs	4
Contemporary strategies to assess and manage liver donor steatosis: a review	4
The impact of biological features for a better prediction of posttransplant hepatocellular cancer recurrence	4
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?	4
Organ allocation and procurement in cardiac transplantation	4
Epigenetic modifications and the development of kidney graft fibrosis	4
Equity in kidney transplant allocation – North American perspective	4
Role of bacteriophage therapy for resistant infections in transplant recipients	3
Hepatitis C-positive liver transplantation: outcomes and current practice	3
Oncologic indications of liver transplantation and deceased donor liver allocation in the United States	3
The road to xenotransplantation	3
Patient selection for heart transplant: balancing risk	3
Social support and transplantation	3
Clinical and biomarker assessment of frailty in liver transplantation	3
Hypothermic machine perfusion for liver graft preservation	3
Multidrug-resistant organisms in lung transplant: a narrative review	3
Measuring human leukocyte antigen alloantibodies: beyond a binary decision	3
Microbiota in heart and lung transplantation: implications for innate-adaptive immune interface	3
Ex-situ liver preservation with machine preservation	3
Kidney and pancreas transplant candidacy	3
Tolerance, immunosuppression, and immune modulation: impacts on lung allograft survival	3
Current status of pediatric intestinal transplant in Europe	3
The evolving role of regulatory reporting on patient and donor selection in organ transplantation	3
Pancreas transplant versus islet transplant versus insulin pump therapy: in which patients and when?	3
Kidney transplant program specific reporting and transplant metrics	3
Cystic fibrosis: candidate selection and impact of the cystic fibrosis transmembrane conductance regulator therapy	3

Artificial neural network and bioavailability of the immunosuppression drug	3
Closing the abdomen: update on the current surgical toolkit	3
DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics?	3
Management of long-term cardiovascular risk factors post organ transplant	3
The role of ex-situ perfusion for thoracic organs	3
The development of artificial livers	3
CMV antiviral stewardship: navigating obstacles to facilitate target attainment	3
Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors	3
Progress and challenges in diagnosis and treatment of rejection following liver transplantation	3
Update and breakthrough in cardiac xenotransplantation	3
The evolving role of advanced practice providers in transplantation: a literature review	3
The current outcomes and future challenges in pediatric vascularized composite allotransplantation	3
Infectious complications of vascularized composite allograft transplantation	3
Donor-specific antibodies in liver transplantation: challenges in diagnosis and determining clinical impact	3
Ischemia-free organ transplantation − a review	3
Profiling the liver graft	3
Emerging fungal pathogens in solid organ transplantation	3
Managing pulmonary arterial hypertension: how to select and facilitate successful transplantation	2
From bench to bedside: reversing established antibody responses and desensitization	2
Durable mechanical circulatory support as bridge to heart transplantation	2
Human immunodeficiency virus from life taking to life giving: expanding the donor pool by using HIV-positive donors	2
Donor-specific antibodies in heart transplantation: can we afford the price or is it too steep to pay?	2
Ex-vivo lung perfusion therapies: do they add value to organ donation?	2
Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions	2
Vascularized composite allotransplantation: emerging psychosocial issues in hand, face, and uterine transplant	2
Living donation – any news on the donor?	2
Deceased donors with multidrug-resistant organisms: implications and future directions	2
Donor-specific antibodies in kidney transplantation: the University of Wisconsin experience	2
‘As a surgeon, I am obliged to every single patient’: evaluation of focus group discussions with transplantation physicians on the allocation of donor organs	2
Repeated kidney re-transplantation in times of organ shortage – a critical review	2
Disease recurrence after gut transplantation	2
Emerging biomarkers in kidney transplantation and challenge of clinical implementation	2
Equity of access to renal transplantation: a European perspective	2
Clostridium difficile disease in solid organ transplant recipients: a recommended treatment paradigm	2
HIV and organ transplantation	2
Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors	2
Liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?	2
Infective endocarditis in solid organ transplant: a review	2
The human microbiome in transplantation: the past, present, and future	2
Current review on the role of ileostomy following intestinal transplantation	2
Are split liver grafts a suitable option in high-risk liver transplant recipients?	2
Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?	2
Donor-derived infections in solid organ transplant recipients	2
Potential options to expand the intestinal donor pool: a comprehensive review	2
Kidney organ allocation: reducing discards	2
How to maximize graft survival	2
Pediatric kidney transplantation, a technical update	2
Two is better than one: when to consider multiorgan transplant	2
Progress towards xenogenic tolerance	2
Modifying organs with gene therapy and gene modulation in the age of machine perfusion	2
The role of machine perfusion in liver xenotransplantation	2
Immune checkpoint inhibitors in kidney transplantation	2
Misplaced emphasis, misunderstood risk: a cultural history of Public Health Service infectious disease guidelines	2
Cardiovascular risk stratification in the noncardiac solid organ transplant candidate	2